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Abstract: The objective of this study was to provide a comprehensive examination of the relation
of complicated and uncomplicated mild traumatic brain injury (mTBI) with multidimensional
outcomes at three- and six-months after TBI. We analyzed data from the Collaborative European
NeuroTrauma Effectiveness Research (CENTER-TBI) research project. Patients after mTBI (Glasgow
Coma scale (GCS) score of 13–15) enrolled in the study were differentiated into two groups based
on computed tomography (CT) findings: complicated mTBI (presence of any traumatic intracranial
injury on first CT) and uncomplicated mTBI (absence of any traumatic intracranial injury on first
CT). Multidimensional outcomes were assessed using seven instruments measuring generic and
disease-specific health-related quality of life (HRQoL) (SF-36 and QOLIBRI), functional outcome
(GOSE), and psycho-social domains including symptoms of post-traumatic stress disorder (PTSD)
(PCL-5), depression (PHQ-9), and anxiety (GAD-7). Data were analyzed using a multivariate repeated
measures approach (MANOVA-RM), which inspected mTBI groups at three- and six-months post
injury. Patients after complicated mTBI had significantly lower GOSE scores, reported lower physical
and mental component summary scores based on the SF-36 version 2, and showed significantly lower
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HRQoL measured by QOLIBRI compared to those after uncomplicated mTBI. There was no difference
between mTBI groups when looking at psychological outcomes, however, a slight improvement
in PTSD symptoms and depression was observed for the entire sample from three to six months.
Patients after complicated mTBI reported lower generic and disease specific HRQoL and worse
functional outcome compared to individuals after uncomplicated mTBI at three and six months.
Both groups showed a tendency to improve from three to six months after TBI. The complicated
mTBI group included more patients with an impaired long-term outcome than the uncomplicated
group. Nevertheless, patients, clinicians, researchers, and decisions-makers in health care should
take account of the short and long-term impact on outcome for patients after both uncomplicated and
complicated mTBI.
Keywords: traumatic brain injury; outcome; generic and disease-specific health-related quality of
life; complicated mild traumatic brain injury; functional outcome
1. Introduction
In the European Union, 1.5 million hospitalizations result from traumatic brain injury (TBI)
annually [1,2]. Approximately 70–90% of patients presenting to hospital are diagnosed with mild TBI
(mTBI), which is generally classified with a Glasgow Coma Scale (GCS) score of 13 to 15 [1]. Williams
et al. elaborated further on this description of mTBI and proposed that intracranial abnormalities
on computed tomography (CT) at presentation should be taken into account. This resulted in
distinguishing patients after complicated (presence of trauma-related intracranial abnormalities and/or
depressed skull fracture on CT) and uncomplicated (absence of intracranial abnormalities and/or
depressed skull fracture on CT) mTBI [3]. The sensitivity of CT has improved over the years, and an
abnormal scan may no longer have the same significance.
Previous research concerning the impact of complicated and uncomplicated mTBI on outcome
has been contradictory. On the one hand, the presence or absence of intracranial abnormalities is seen
as relevant to prognosis, since complicated mTBI has been associated with cognitive and functional
outcome comparable to patients after moderate TBI (GCS 9–13) [3–6]. In contrast, other studies
have shown no relationship between complicated mTBI and cognitive and functional outcome [7–9].
Additionally, previous research reported divergent results concerning longitudinal outcome after
complicated and uncomplicated mTBI. In some studies, patients after complicated mTBI reported worse
outcome than individuals after uncomplicated mTBI [7,10,11]. While others observed improvement in
patients after complicated mTBI over time and showed slower recovery in the uncomplicated mTBI
group [12]. A few studies even found no significant differences between the two groups [7,9].
In previous research, the focus on complicated and uncomplicated mTBI research has mainly
been on neurocognitive and functional outcome, and post-concussion symptoms [4,5,7,11,13–15].
However, nowadays, generic, and disease-specific health-related quality of life (HRQoL) have been
acknowledged as an important outcome after TBI [16,17] for both patients and clinicians. HRQoL
reflects an individual’s perception of how an illness and its treatment affect the physical, mental,
cognitive, and social aspects of someone’s life [16,18,19].
Despite an abundance of studies and decades of research on complicated and uncomplicated
patients after mTBI, only few studies have examined HRQoL outcomes in patients after complicated
and uncomplicated mTBI [20] and differences regarding outcome between these groups remain poorly
understood. There has not yet been a study with a large sample size, taking longitudinal changes into
account, and the ability to compare patients on different outcome domains: generic and disease specific
HRQoL, functional outcome and symptomatology, such as post-traumatic stress, depression and
anxiety. Moreover, the authors of the present study are not aware of any studies using a multivariate
approach when exploring HRQoL, functional and psychological outcomes in adult patients [21].
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As (m)TBI may affect different areas simultaneously, it is important to investigate the differences
between groups by using multidimensional approaches [22].
We hypothesize that patients after complicated mTBI report lower generic and disease specific
HRQoL and worse functional outcomes compared to uncomplicated mTBI at three and six months.
Additionally, we do not expect considerable improvement in outcome from three to six months.
More insight is needed regarding the impact of complicated mTBI compared to uncomplicated
mTBI on outcome from a longitudinal perspective. Therefore, the objective of this study was to
provide a comprehensive multidimensional approach in analyzing the effects of complicated and
uncomplicated mTBI on outcome in a large sample of individuals at three- and six-months post-injury.
2. Materials and Methods
2.1. Study Design
In this study, we analyzed patients who were enrolled in the Collaborative European NeuroTrauma
Effectiveness Research (CENTER-TBI) research project. This is a multicenter, prospective, observational,
longitudinal cohort study, which was conducted in Europe and Israel [1,23]. Patients with all severities
of TBI who presented to hospital were included between 19 December 2014 and 17 December 2017.
A clinical diagnosis of TBI, an indication for a CT scan, presenting to a center within 24 h after the injury,
and informed consent were used as inclusion criteria. Informed consent, adhering to local and national
requirements, had to be obtained prior to inclusion, either personally or through a legally acceptable
representative. At any point in time during the study, patients were free to withdraw without stating a
reason. Patients with severe pre-existing neurological disorders, which could invalidate assessment
of outcomes, were excluded. Patients were recruited in three strata: emergency room (ER; patients
evaluated at the ER and discharged afterwards), admission (ADM; patients admitted to hospital
ward), and intensive care unit (ICU; patients who were primarily admitted to the ICU) [23]. The main
descriptive findings of CENTER-TBI can be found in Steyerberg et al. [24].
2.2. Study Participants
In the current study analysis, participants were included if they had mTBI (GCS 13–15). They were
differentiated into two groups: complicated and uncomplicated mTBI. Complicated mTBI was specified
as the presence of any traumatic intracranial abnormalities on first CT scan and uncomplicated was
specified as absence of any traumatic intracranial abnormality on first CT. The presence of intracranial
abnormality was defined as the detection of at least one of the following twelve findings on CT
scan: mass lesion, extra axial hematoma, epidural hematoma, acute or chronic subdural hematoma,
one or multiple subdural collections/mixed density hematomas, contusion, traumatic axonal injury
(TAI), traumatic subarachnoid hemorrhage, intraventricular hemorrhage, midline shift, or cisternal
compression. In the current study, a linear or depressed skull fracture, in the absence of structural
intracranial abnormalities, was not considered as a criterion for complicated mTBI, however, this
has been used as a determinant of intracranial abnormalities in previous research. Furthermore,
participants had to be ≥16 years of age and classified as GOSE ≥3.
The American Society of Anesthesiologists Physical Status Classification System (ASA-PS) was
used to assess individuals’ health status before the injury [25].
For all analyses, a complete case analysis for the following variables at three and six months was
performed: SF-36, QOLIBRI, GOSE, PCL-5, PHQ-9, and GAD-7. For more details, see Figure 1.
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Figure 1. Flowchart sample size. Abbreviations: N = number; mTBI = mild traumatic brain injury;
GOSE = Glasgow Outcome Scale—Extended; TBI = traumatic brain injury; SF-36 PCS = Short Form
(36) Health Survey (physical component score); SF-36 MCS = Short Form (36) Health Survey (mental
component score); QOLIBRI = Quality of Life after Brain Injury; PCL-5 = Posttraumatic Stress Disorder
Checklist; PHQ-9 = Patient Health Questionnaire; GOSE = Glasgow Outcome Scale—Extended;
GAD-7 = Generalized Anxiety Disorder questionnaire
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2.3. Instruments
Outcome was assessed as a multidimensional construct by using seven instruments measuring
generic and disease-specific HRQoL, functional outcome, and psycho-social domains including
post-traumatic stress, depression, and anxiety. The following measures were analyzed:
2.3.1. Health-Related Quality of Life (HRQoL)
Generic HRQoL. The 36-item Short Form (SF-36v2) Health Survey is a multidimensional
self-report questionnaire measuring the subjective health state including physical, mental, and
social functioning [26]. The questionnaire comprises 36 items covering eight domains and applies
different response scales from a dichotomous (“yes”/”no”) to a polytomous five-point Likert scale. For
more information see Ware et al. [26]. For our analyses, we used the two summary component scores:
the physical component summary (PCS) and mental component summary (MCS) score, which measure
physical functioning and mental health, respectively. The total score of the SF-36 ranges from 0 to 100,
whereby higher values indicate higher HRQoL, and total scores below 40 are considered impaired [27].
Disease specific HRQoL. The Quality of Life after Brain Injury (QOLIBRI) is a 37-item self-report
instrument that measures level of satisfaction with various aspects of TBI-specific HRQoL [28]. It entails
six scales evaluating key aspects of life: the first four scales assess ‘satisfaction’ with cognition, self,
daily life and autonomy and social relationships and the last two scales measure ‘feeling bothered’ with
emotions and physical problems. Responses are given on a five-point Likert scale which extends from
0 (“not at all”) to 4 (“very”). The total score was transformed linearly to range from 0 to 100; higher
values indicate better HRQoL [28]. For the QOLIBRI, scores below 60 are considered impaired [29].
2.3.2. Functional Outcome
Glasgow Outcome Scale—Extended (GOSE) measures functional outcome after TBI. Functional
outcome is rated by a clinician on an eight point scale: 1 (dead), 2 (vegetative state), 3 (lower sever
disability), 4 (upper severe disability), 5 (lower moderate disability), 6 (upper moderate disability), 7
(lower good recovery) and 8 (upper good recovery) and is derived from eight questions [30]. In the
present study, functional impairment was classified as a GOSE score ≤6 [31]. Structured interviews
and self-report questionnaires were used to collect the GOSE. A multistate model was used to impute
the 180-day GOSE when patients scores were outside the 5- to 8-month window (msm R package) [32].
Patients with GOSE 1 (dead) were excluded from analyses, and GOSE levels 2 and 3 were collapsed
into one.
2.3.3. Post-Traumatic Stress, Depression, and Anxiety
The Post-traumatic Stress Disorder Checklist-5 (PCL-5) [33] measures 20 symptoms of
post-traumatic stress disorder (PTSD) based on the Diagnostic and Statistical Manual of Mental
Disorders, 5th edition (DSM-V) [34] by using a five-point scale (from 0 “not at all” to 4 “extremely”).
The total score ranges from 0 to 80, whereby higher values indicate greater impairment and a score of
≥33 is considered indicative of clinically relevant PTSD [35].
The Patient Health Questionnaire (PHQ-9) [36] is a nine item self-assessment instrument evaluating
depression symptoms in the past two weeks using a four-point Likert scale (from 0 “not at all” to 3
“nearly every day”) based on DSM-IV criteria [37]. The maximum score is 27 and the higher the score,
the greater the indication for depressive symptoms. A score of ≥10 is seen as a strong indication for
clinically relevant depressive symptoms and cutoffs of 5, 10, 15 and 20 indicate mild, moderate, and
moderately severe to severe depressive symptoms, respectively [36,38].
The Generalized Anxiety Disorder questionnaire (GAD-7) [39] measures anxiety symptoms in the
past two weeks by using seven items with a four-point scale (from 0 “not at all” to 3 “nearly every
day”). The total score ranges from 0 to 27. A score of ≥10 is generally seen as an indicator for the
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presence of anxiety disorder and cutoffs 5, 10 and 15 indicate mild, moderate, and severe anxiety,
respectively [39].
2.4. Ethical Approval
The CENTER-TBI study (EC grant 602150) was conducted in accordance with all relevant laws of
the EU if directly applicable or of direct effect, and all relevant laws of the country where the recruiting
sites were located, including, but not limited to, the relevant privacy and data protection laws and
regulations (the “Privacy Law”), the relevant laws and regulations on the use of human materials, and
all relevant guidance relating to clinical studies from time to time in force including, but not limited to,
the ICH Harmonised Tripartite Guideline for Good Clinical Practice (CPMP/ICH/135/95) (“ICH GCP”)
and the World Medical Association Declaration of Helsinki entitled “Ethical Principles for Medical
Research Involving Human Subjects”. Ethical approval was obtained for each recruiting site. Informed
Consent was obtained for all patients recruited in the Core Dataset of CENTER-TBI and documented
in the e-CRF. The list of sites, Ethical Committees, approval numbers, and approval dates can be found
on the official Center TBI website www.center-tbi.eu/project/ethical-approval.
2.5. Statistical Analyses
For all analyses, data was extracted from the INCF Neurobot tool (INCF, Solna, Sweden), a clinical
study data management tool. Core data set version 2.1 (data frozen in January 2019) was used for all
analyses in this manuscript. Descriptive analyses for care paths, demographic and socio-economic
characteristics, pre-injury health status and medical history, cause of injury, clinical presentation,
CT characteristics, SF-36 MCS and SF-36 PCS, PCL-5, PHQ-9, GAD-7, QOLIBRI, and GOSE were
performed and analyzed for patients with complicated and uncomplicated mTBI at three and six
months post-injury. Descriptive statistics show the number (N) and percentages (%) for categorical
variables and median and interquartile range (IQR) for continuous and ordinal variables. To compare
individuals after complicated mTBI to uncomplicated mTBI, Chi-square tests and Mann–Whitney
U-tests were used for categorical and continuous variables, respectively.
We compared individuals with a least one impaired outcome with those classified as not impaired
at all (i.e., each outcome value did not exceed respective cut-off value). For analyses of individuals
who were classified as impaired according to the cut-off values of unfavorable outcome for each
outcome variable, new variables with classification (impaired vs. not impaired) were calculated for
each dependent variable separately. See the instrument descriptions for the respective selected cut-off
values. Distributions of individuals classified as reporting impaired outcome within mTBI groups
were compared by using Chi-square tests for both three and six months after TBI.
Data were analyzed using a multivariate repeated measures approach (MANOVA-RM), suitable for
non-normal data with covariance heterogeneity, to provide robust test statistics [40,41]. The outcome
construct (dependent variables) consisted of seven instruments assessing outcomes (SF-36 MCS
and SF-36 PCS, PCL-5, PHQ-9, GAD-7, QOLIBRI, and GOSE). The between effect was defined by
complicated and uncomplicated mTBI groups. The within effect was defined by time points (three and
six months after mTBI).
For post hoc comparisons, we used repeated measures ANOVAs for non-normal data and
significance was assessed at α < 0.007, applying a Bonferroni-adjustment (αadj = 0.057 ).
All analyses were conducted using R version 3.6.1 [42] with application of the MANOVA-RM
package [40] for both MANOVA-RM and post-hoc repeated measures ANOVAs. Supplementary
material gives a detailed overview of the methodology. The significance level was determined as
α < 0.05 for Chi-square tests, Mann–Whitney U-tests, and multivariate analysis and α < 0.007 for post
hoc comparisons between groups.
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3. Results
3.1. Study Sample
The total CENTER-TBI cohort included 2955 patients after mTBI and our study sample consisted
of 1104 patients (37.4%) who were interviewed at both time points (3- and 6-months after mTBI) and
completed all seven outcomes. Included patients were admitted to the ER (30.6%), ADM (47.6%), or the
ICU (21.8%) and had sustained either uncomplicated mTBI (48.5%) or complicated mTBI (51.5%). The
mean age of individuals after mTBI was 52.3 years (SD = 18.8) and 63.4% were male. The majority were
injured by a fall (47%) or traffic incident (39%) and approximately 11% reported having experienced
a TBI previously. Patients after complicated mTBI were significantly older (mean age: 54.5 vs. 50.3)
compared to those after uncomplicated mTBI and were less likely to be classified as “working”,
however, they less often reported a previous TBI (p < 0.01). Patients after complicated mTBI were more
often classified with a GCS score of 13 and 14. For more details, see Table 1.
Table 1. Characteristics of the study sample.
Study Sample Uncomplicated Complicated p-Value
N 1104 569 (51.5%) 535 (48.5%)
Care paths <0.01
ER 338 (30.6%) 286 (50.3%) 52 (9.7%)
Admission 525 (47.6%) 236 (41.5%) 289 (54.0%)
ICU 241 (21.8%) 47 (8.3%) 194 (36.3%)
Demographic characteristics
Gender (male) 700 (63.4%) 352 (61.9%) 348 (65.0%) 0.272
Age 1 (years) 54 [37.3–67] 51 [35–65] 58 [40–68] <0.01
Socio-economic characteristics
Education 1 (years) 14 [12–17] 14 [12–17] 14 [11–17] 0.054
Employment status before injury
Working 2 593 (53.7%) 331 (58.2%) 262 (49.0%) <0.01
Pre-injury health status and medical
history
Pre-injury ASA-PS classification 0.175
A patient with mild systemic disease 377 (34.1%) 181 (31.8%) 196 (36.6%)
A patient with severe systemic disease 106 (9.6%) 60 (10.5%) 46 (8.6%)
Previous TBI 129 (11.7%) 84 (14.8%) 45 (8.4%) <0.01
Cause of injury
Injury Mechanism 0.409
Road traffic accident 429 (38.9%) 222 (39.0%) 207 (38.7%)
Incidental fall 517 (46.8%) 265 (46.6%) 252 (47.2%)
Other non-intentional 60 (5.4%) 36 (6.3%) 24 (4.5%)
Violence/assault 38 (3.4%) 19 (3.3%) 19 (3.6%)
Act of mass violence 1 (0.1%) - 1 (0.2%)
Suicide attempt 7 (0.6%) 2 (0.4%) 5 (0.9%)
Other 36 (3.3%) 20 (3.5%) 16 (3.0%)
Unknown 16 (1.4) 5 (0.9%) 11 (2.1%)
Clinical presentation
GCS baseline 1 15 [15–15] 15 [15–15] 15 [14,15] <0.01
13 65 (5.9%) 9 (1.6%) 56 (10.5%)
14 155 (14.0%) 53 (9.3%) 102 (19.1%)
15 884 (80.1%) 507 (89.1%) 377 (70.5%)
CT characteristics
Computed Tomography
Any intracranial injury on first CT 535 (48.5%) 0 (0.0%) 535 (100%) <0.01
1 Data are displayed as median, with the first and third quartile given within brackets. 2 Working = working 35 h or
more per week; working 20–34 h per week; working less than 20 h per week and/or special employment/sheltered
employment. Abbreviations: mTBI: mild traumatic brain injury; ER: emergency room; ICU: intensive care unit;
ASA-PS: The American Society of Anaesthesiologists (ASA) Physical Status Classification System; TBI: traumatic
brain injury; GCS: Glasgow Coma Scale; CT: Computed Tomography.
3.2. Descriptive Statistics of Outcomes
Figure 2 provides an overview on outcome instruments and uncomplicated and complicated
mTBI groups and time points. Patients after complicated mTBI reported both lower generic (PCS and
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MCS scores) and lower disease-specific HRQoL (QOLIBRI), lower functional outcome (GOSE), higher
PCL-5, PHQ-9, and GAD-7 scores compared to individuals after uncomplicated mTBI at both time
points. In general, small differences were observed for both groups between 3 and 6 months.
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indicate the mean value. Abbreviations. mTBI = mild trau atic brain injury; SF-36 PCS = Short
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Appendix A provides mean values (M) and standard deviations (SD) for the seven outcomes
clustered in the two mTBI groups and time points.
Patients were considered impaired when the corresponding cut-offs were reached. The percentage
of impaired individuals (i.e., with at least one of the seven outcomes being impaired) in the total sample
was 53% at three months and 49% at six months after TBI. In the uncomplicated mTBI group, 51% and
49% were classified as impaired at three and six months, respectively. In the complicated mTBI group,
53% at three months and 48% at six months had at least one impaired outcome. For development of
impaired outcomes in individuals after uncomplicated and complicated mTBI at three and six months,
see Appendix B.
For both mTBI groups, there were patients included in our study sample who could be considered
as reporting impaired outcomes. Therefore, these individuals with impaired outcomes were inspected
separately. Table 2 gives an overview for each dependent variable by uncomplicated and complicated
mTBI groups at three- and six-months post-injury.
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Table 2. Percentages of impaired individuals according to the respective cut-off values.
Outcome Time Points Uncomplicated mTBI(n = 569)
Complicated mTBI
(n = 535)
SF-36 PCS
3mo 24% 29%
6mo 21% 22%
SF-36 MCS
3mo 22% 30%
6mo 21% 28%
PCL-5
3mo 10% 10%
6mo 8% 10%
PHQ-9 3mo 16% 19%
6mo 16% 16%
GAD-7
3mo 11% 13%
6mo 8% 11%
QOLIBRI 3mo 19% 26%
6mo 19% 21%
GOSE
3mo 23% 41%
6mo 16% 35%
Abbreviations: mTBI = mild traumatic brain injury; 3mo = 3 months; 6mo = 6 months; SF-PCS = Short Form
(36) Health Survey (physical component score); SF-MCS = Short Form (36) Health Survey (mental component
score); PCL-5 = Posttraumatic Stress Disorder Checklist; PHQ-9 = Patient Health Questionnaire; GAD-7 =
Generalized Anxiety Disorder questionnaire; QOLIBRI = Quality of Life after Brain Injury; GOSE = Glasgow
Outcome Scale—Extended; n = number of cases. Note. Cut-off values: SF-36 PCS and SF-36 MCS < 40, PCL-5 ≥ 33,
PHQ-9 ≥ 10, GAD-7 ≥ 10, QOLIBRI < 60, GOSE ≤ 6.
At three months post TBI, there were significantly more individuals with impaired outcomes after
complicated mTBI according to SF-36 MCS score, QOLIBRI, and GOSE (p < 0.05). Concerning the
GOSE scale, 41% of patients after complicated mTBI were considered to be impaired (cut-off value ≤ 6)
and 23% of the individuals after uncomplicated mTBI. Additionally, more patients with impaired
generic (SF-36 MCS < 40) and disease-specific (QOLIBRI < 60) HRQoL were observed within the
complicated mTBI group (for details, see Table 2).
At six months after TBI, we observed significantly more individuals with impaired outcomes
after complicated mTBI according to the GOSE scale (p < 0.05). More than one third of the patients
after complicated mTBI showed impairments on the GOSE, compared to 16% of individuals after
uncomplicated mTBI. Among the other outcomes, the distribution within mTBI group was equal.
3.3. MANOVA-RM
MANOVA-RM showed significant differences between complicated and uncomplicated mTBI
groups as well as between time points. No significant interaction was found between both main effects.
There were significant differences between mTBI groups in three (generic and disease-specific HRQoL
and functional outcome) out of seven outcomes. All but one domain (i.e., anxiety) differed between
both time points (see Table 3 for test statistics).
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Table 3. Results of repeated measures MANOVA and repeated measures ANOVA.
Analysis DependentVariable(s)
Independent
Variable (M)ATS df1 df2 p
MANOVA
RM
Multiple
outcomes *
mTBI 197.538 - - <0.001
Time points 34.708 - - <0.001
mTBI: Time points 2.932 - - 0.158
ANOVA
RM
SF-36 PCS
mTBI 5.897 1 1365.422 0.015
Time points 61.133 1 - <0.001
mTBI: Time points 4.361 1 - 0.037
SF-36 MCS
mTBI 7.879 1 1399.985 0.005
Time points 10.502 1 - 0.001
mTBI: Time points 3.058 1 - 0.080
PCL-5
mTBI 5.481 1 1366.071 0.019
Time points 16.902 1 - <0.001
mTBI: Time points 0.653 1 - 0.448
PHQ-9
mTBI 2.632 1 1386.136 0.114
Time points 9.075 1 - 0.005
mTBI: Time points 0.032 1 - 0.848
GAD-7
mTBI 3.216 1 1425.187 0.073
Time points 3.137 1 - 0.077
mTBI: Time points 0.026 1 - 0.872
QOLIBRI
mTBI 12.25 1 1337.174 <0.001
Time points 8.588 1 - 0.003
mTBI: Time points 2.980 1 - 0.084
GOSE
mTBI 80.944 1 1444.067 <0.001
Time points 26.15 1 - <0.001
mTBI: Time points 1.057 1 - 0.304
Note: TBI severity = between effect (uncomplicated and complicated mTBI); Time = within effect (time points 3
and 6 months after TBI); p = p-value based on parametric bootstrapping ((M)ATS). Bold p-values are significant
at α = 0.05 for MANOVA-RM and αadj = 0.007 for ANOVA-RM, respectively. * Multiple outcomes = all seven
outcomes combined as a dependent variable. Abbreviations. (M)ATS = (multivariate) ANOVA-type statistic; df1/df2
= degrees of freedom; p = p-value; TBI = traumatic brain injury; SF-PCS = Short Form (36) Health Survey (physical
component score); SF-MCS = Short Form (36) Health Survey (mental component score); PCL-5 = Posttraumatic Stress
Disorder Checklist; PHQ-9 = Patient Health Questionnaire; GAD-7 = Generalized Anxiety Disorder questionnaire;
QOLIBRI = Quality of Life after Brain Injury; GOSE = Glasgow Outcome Scale—Extended.
3.4. Post-Hoc Comparisons
Table 4 provides an overview on differences between mTBI groups, time points, and interaction
between both effects according to the results of ANOVA-RM.
Table 4. Overview of differences between mTBI groups, time points, and interaction between both effects.
Outcome mTBI Time Points Interaction
SF-36 PCS – ++ –
SF-36 MCS ++ ++ –
PCL-5 – ++ –
PHQ-9 – ++ –
GAD-7 – – –
QOLIBRI ++ ++ –
GOSE ++ ++ –
Note: ++ = significant on α = 0.007, – not significant. Abbreviations. mTBI = mild traumatic brain injury;
SF-PCS = Short Form (36) Health Survey (physical component score); SF-MCS = Short Form (36) Health Survey
(mental component score); PCL-5 = Posttraumatic Stress Disorder Checklist; PHQ-9 = Patient Health Questionnaire;
GAD-7 = Generalized Anxiety Disorder questionnaire; QOLIBRI = Quality of Life after Brain Injury; GOSE =
Glasgow Outcome Scale—Extended.
Post-hoc comparisons revealed, in contrast to the multivariate results, a more detailed insight
into differences between the main effects and their interaction for each dependent variable. Therefore,
differences between mTBI groups and time points for the seven outcomes are reported separately. It is
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important to note that, with the exception of the mean depression score in the complicated mTBI group,
all other outcomes were on average above the clinically relevant cut-off points.
3.4.1. Health-Related Quality of Life
Generic HRQoL. The PCS (SF-36) showed a significant within effect with an increase in HRQoL
from three (M = 46.52, SD = 10.43) to six months (M = 48.10, SD = 10.21) after TBI.
The MCS (SF-36) revealed significant differences between both the mTBI groups and the observed
time points. Individuals after uncomplicated mTBI (M = 48.43, SD = 11.01) reported significantly
higher HRQoL compared to those after complicated mTBI (M = 46.61, SD = 12.07). There was a slight
but significant increase of MCS score from three (M = 47.14, SD = 11.57) to six months (M = 47.95,
SD = 11.56) after mTBI.
Disease-specific HRQoL. For the QOLIBRI, significant differences between both mTBI groups
and time points were reported. HRQoL was significantly higher in the uncomplicated mTBI group
(M = 74.97, SD = 16.82) compared to the complicated mTBI group (M = 71.56, SD = 17.33). In addition,
an increase of HRQoL was observed between three (M = 72.84, SD = 17.05) and six months (M = 73.79,
SD = 17.24) following mTBI for both groups.
3.4.2. Functional Outcome
For the GOSE, significant differences in both the between and within effects were detected. Patients
after complicated mTBI showed significantly higher disability levels (M = 6.63, SD = 1.37) compared to
those with uncomplicated mTBI (M = 7.24, SD = 1.08). A significant increase concerning recovery was
observed for both groups from three (M = 6.86, SD =1.301) to six months (M = 7.02, SD = 1.23).
3.4.3. Post-Traumatic Stress, Depression, and Anxiety
Results showed a significant decrease of PTSD related symptoms (PCL-5) from three (M = 12.54,
SD = 13.44) to six months (M = 11.41, SD = 12.98) after mTBI. Depression related symptoms measured
by the PHQ-9 were slightly but significantly higher for three (M = 4.93, SD = 5.04) compared to six
months (M = 4.61, SD = 5.01) after mTBI. Anxiety measured by GAD-7 revealed no significance either
between mTBI groups or between time points.
4. Discussion
This study focused on the outcome of patients, included in a large European database, after
complicated and uncomplicated mTBI at three- and six-months post-injury. The results may contribute
significantly to existing literature concerning this topic. A better understanding of the relation between
complicated and uncomplicated mTBI and different outcomes may improve intervention strategies
and the recovery process of patients after mTBI.
When comparing individuals after complicated and uncomplicated mTBI, patients after
complicated mTBI reported lower generic and disease specific HRQoL and worse functional outcome
at both time points. Nevertheless, we did not find considerable improvement in outcomes from three
to six months as mean scores on all outcome measures were within average range and not classified
as impaired. The mean PHQ-9 score for patients after complicated mTBI at three months post-injury
reached the cut-off for mild depressive symptoms, which indicates the need for an appropriate
follow-up and early treatment. It is noteworthy that the number of individuals with impaired
functional and psychological outcomes was considerably higher in the complicated mTBI group
than in the uncomplicated group, especially three months post-injury. Therefore, one should ensure
that these patients are detected early, and their health status should be monitored longitudinally, to
provide targeted and timely treatment. Ultimately, the differences between some measures were small
and significant baseline differences between the groups might contribute to the reported findings.
Especially, when keeping in mind that patients after complicated mTBI were often more severely
injured according to the GCS score.
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In previous research, nearly 40% of patients with mTBI reported depressive symptoms within
three to six months post-injury [43]. In addition, 33% of patients with mTBI were functionally
impaired three months post-injury [13]. When specifically focusing on individuals after complicated
and uncomplicated mTBI, contradictory results have been reported regarding the impact of
complicated and uncomplicated mTBI on outcome. Ponsford et al. found that the majority of
individuals after uncomplicated mTBI make a good recovery on average 7 months post-injury, when
focusing on post-concussion symptoms, depression/anxiety and mental and physical quality of life
scores [44]. In various studies, complicated mTBI is seen as a key component when predicting
outcome [3–6]. However, other research did not find any relation between functional outcome and
complicated mTBI [7–9]. Furthermore, HRQoL has been under-investigated in previous research and
a multidimensional approach to outcome assessment such as in this study has been lacking.
The present study is novel because there has not yet been a study with such a large sample size
and simultaneously having the ability to compare patients on different outcome levels such as generic
and disease-specific HRQoL, functional outcome, and symptomatology. Moreover, the methodology
used in this study strengthened the results, since a multivariate statistical approach suitable for
non-normal distributed data with less assumptions and restrictions as in most other research was
applied. In particular, the method combines information from multiple outcome measures and is also
suitable for non-normal data.
Several limitations concerning this study should be taken into account. It is important to note that
the effect sizes were small for the PCS and MCS scores and PHQ-9, and statistical significance was
most likely due to the sample size used in this study. Resilience and coping, which was not measured
in this study, might have impacted outcome. Maestas et al. reported that pre-injury coping in the
sense of strengthening resilience could impact outcome after uncomplicated and complicated mTBI as
coping may impact resilience [20]. Williams’ classification of complicated versus uncomplicated may
underestimate the presence and type of TBI abnormalities as routine magnetic resonance imaging has
proven to be far more sensitive and is the preferable tool [45]. Generalizability of the results presented
in this study is restricted since adjustment for baseline covariates between the two groups was not
provided. In the current study implications of treatment after mTBI have not been accounted for,
which could influence the course of recovery after mTBI. Lastly, patients who are still experiencing
lower HRQoL and lower functional outcome might have been more likely to participate, resulting in
response bias [46].
For future research it would be interesting to look at outcome at later follow-up times such as
five to ten years post-TBI. In addition, return to work or school after complicated and uncomplicated
mTBI should be assessed since this could influence subjective well-being [47], and has a major impact
on societal costs [1]. Furthermore, research into biomarkers and localization of the abnormality on
CT or magnetic resonance imaging scans can refine the conclusions drawn in this study [1,10]. Lastly,
to establish a better understanding considering outcome after complicated and uncomplicated mTBI,
outcomes in this study should be compared to patients with non-brain injured trauma as well as the
general population, and complicated and uncomplicated mTBI groups should be further differentiated
by GCS score.
5. Conclusions
To conclude, the present results indicate that patients after complicated mTBI reported lower
generic and disease specific HRQoL and worse functional outcome compared to patients after
uncomplicated mTBI at three and six months. However, differences between some measures were
small and there were significant baseline differences between the groups that might contribute to the
findings. Both groups showed a tendency to improve on outcome from three to six months after TBI.
Additionally, the complicated mTBI group comprised more patients with impaired outcomes than
the uncomplicated group. Considering this, patients, clinicians, researchers, and decisions-makers
in health care should be taking the short and long-term effects on outcome for patients after both
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uncomplicated and complicated mTBI into account. At the same time, individually tailored therapy
should be provided early on for those who show deficiencies in recovery, HRQoL, psychological and
psychosocial outcomes.
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Appendix A
Table A1. Descriptive statistics on outcomes by uncomplicated and complicated mTBI groups.
Uncomplicated mTBI
(n = 569)
Complicated mTBI
(n = 535)
Outcome Time Points M SD M SD
SF-36 PCS
3mo 47.41 10.56 45.56 10.22
6mo 48.58 10.37 47.59 10.01
SF-36 MCS
3mo 48.24 10.89 45.98 12.14
6mo 48.62 11.12 47.24 11.98
PCL-5
3mo 11.80 13.00 13.33 13.86
6mo 10.45 12.39 12.42 13.51
PHQ-9 3mo 4.69 4.90 5.17 5.18
6mo 4.40 4.92 4.84 5.10
GAD-7
3mo 3.35 4.25 3.77 4.65
6mo 3.15 4.02 3.61 4.64
QOLIBRI 3mo 74.77 16.46 70.79 17.45
6mo 75.17 17.18 72.32 17.20
GOSE
3mo 7.17 1.10 6.53 1.42
6mo 7.30 1.06 6.73 1.32
Abbreviations. mTBI = mild traumatic brain injury; 3mo = 3 months; 6mo = 6 months; SF-PCS = Short Form (36)
Health Survey (physical component score); SF-MCS = Short Form (36) Health Survey (mental component score);
PCL-5 = Posttraumatic Stress Disorder Checklist; PHQ-9 = Patient Health Questionnaire; GAD-7 = Generalized
Anxiety Disorder questionnaire; QOLIBRI = Quality of Life after Brain Injury; GOSE = Glasgow Outcome
Scale—Extended; n = number of cases; M = mean; SD = standard deviation.
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Figure A1. Development of impaired outcomes in individuals after uncomplicated and complicated mTBI at three and six months. 3 Figure A1. Development of paired outcomes in ndividuals after uncomplicated and complicated mTBI a three and six months.
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